Signal Detection

Signal detection process is a set of activities performed to determine whether, based on an examination of individual case safety reports (ICSRs), aggregated data from active surveillance systems o

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

The submission of data on medicines by marketing-authorisation holders into the EVMPD is a legal requirement from the

Core reimbursement dossier

A core reimbursement dossier is submitted during the late stage of development of a product, in order to be considered for reimbursement.

Cost-Effectiveness

Cost-effectiveness is the ratio of the cost of a therapeutic or preventive intervention to a relevant measure of its effect.

Core value dossier

Core value dossiers are used in the frame of reimbursement negotiations and to support HTA submissions, as well as national and local payers.

Clinical Study Report (CSR)

Upon completion of a clinical trial, the sponsor is required to prepare a detailed report on the study.

End of Trial (EoT) declaration

Clinical trial sponsors are required to notify regulatory authorities and ethics committees when their clinical trials have ended.

EudraCT form

A harmonized application form is used for clinical trial applications across the European Union.

Post-Authorization Safety Study (PASS)

A Post-Authorization Safety Study (PASS) is a study performed after the marketing authorization and aiming principally to further evaluate the safety of the medicinal product or to measure the effe

Post-Authorization Efficacy Study (PAES)

A Post-Authorization Efficacy Study (PAES) is a study performed after the marketing authorization and aiming principally to further evaluate the efficacy of the medicinal product.

Pages